|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS
|
The Clinical and Translational Research Course for PhD Students is a two-week intensive introductory course for graduate students in the basic biomedical sciences who have at least one year of graduate study. The purpose of the course is to demonstrate and highlight the roles of PhD scientists in clinical and translational research, to provide an overview and examples of how basic science and clinical observations lead to translational research, and to increase awareness and access to PhD role models, research resources, and potential career opportunities at the National Institutes of Health (NIH).
|
|
Clinical and Translational Serology Task Force (CTTF)
|
Resource Development
|
CDC, FDA, ASPR
|
NCI, NIAID
|
The National Cancer Institute established a taskforce to catalyze translation of research findings into public health changes. The task force brings together government, academia and industry to provide relevant tools and information related to serology testing to help decisionmakers manage the current and future status of the SARS-CoV-2 pandemic. The task force includes scientists from several disciplines, clinicians, regulatory and public policy experts, and patient advocates.
|
|
Clinical Decision Support Connect Work Group (CDS Connect Work Group)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, ONC
|
NLM, NCI
|
The CDS Connect Work Group advises the CDS Connect team on the ongoing identification and prioritization of key features and capabilities for CDS Connect, leveraging the expertise of work group members. The CDS Connect Work Group was established with focused yet diverse representation to ensure a range of perspectives are heard concerning this work. The direct and iterative input from the work group supports the effective and efficient use of AHRQ’s resources supporting the CDS Connect project (https://cds.ahrq.gov/cdsconnect), which uses VSAC and other NLM terminology resources in its clinical support tooling.
|
|
Clinical Genome Resource and Genetic Testing Reference Material Program Collaborative Project (ClinGen and GeT-RM Collaborative Project)
|
Resource Development
|
CDC
|
NHGRI
|
ClinGen has partnered with the;Centers for Disease Control and Prevention's Genetic Testing Reference Materials Program (or GeT-RM) to develop a publicly available list of expert curated, clinically important genomic variants that provides a foundation for designing comprehensive validation studies and for creating in silico reference materials for clinical genomic test development and validation. In August 2021, ClinGen and GeT-RM published their results in the Journal of Molecular Diagnostics. To assemble the expert curated variant list, members from 36 of ClinGen’s Expert Panels were asked to nominate clinically important variants, including SNPs, CNVs, difficult-to-sequence regions, and complex rearrangements. 546 genomic variants in 84 genes were nominated, including 29 genes on the American College of Medical Genetics and Genomics Secondary Findings v3.0 List. The nominated variants relate to a wide range of diseases, including heritable cancers, inborn errors of metabolism, cardiomyopathy, diabetes, and immune disorders. ClinGen and GeT-RM will continue to solicit feedback from the community and update the list on a regular basis.
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
This working group discusses a range of issues relevant to the development of antiviral drugs for the treatment of influenza.
|
|
Clinical Research Using Medicare Data from the Virtual Research Data Center (VRDC)
|
Research Initiative
|
CMS
|
NLM
|
The National Library of Medicine (NLM) is working with the Centers for Medicare and Medicaid Services (CMS) and other National Institutes of Health (NIH) institutes and centers (ICs) to demonstrate the value of the CMS Virtual Research Data Center (VRDC) as a source of Big Data. ;NLM's Clinical Data Discovery branch uses the VRDC to answer useful epidemiologic and clinical questions, specifically about drug benefits and possible harms.
|
|
Clinical Utilization Plan for Anthrax Medical Countermeasure Use in a Mass Casualty Event (CUPAC) Medical Countermeasures Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC
|
The National Institutes of Health (NIH) Clinical Center is participating as a member of the Medical Countermeasures Work Group to provide clinical algorithms that will assist clinicians to evaluate, triage, diagnose and treat large numbers of patients presenting with symptoms of anthrax. It will also provide a clinical prioritization schema for the use of medical countermeasures specific to anthrax and outline unique critical care issues that may require special consideration.
|
|
Clinical Vocabulary and Standards Development for Meaningful Use of Electronic Medical Records
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, IOS
|
NLM
|
The National Library of Medicine (NLM) collaborates with the Office of the Secretary OS and the Department of Health and Human Services (HHS) Office of the National Coordinator for Health Information Technology (ONC) and other parts of HHS on developing and disseminating regulatory language related to health information technology, meaningful use, and standards and certification criteria related to electronic health records and messaging.
|
|
CMS End-stage Renal Disease (ESRD) Affinity Group
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
NIDDK
|
The Centers for Medicare and Medicaid Services (CMS) has established a number of affinity groups to focus groups of individuals interested in and working on particular topics -- in this case, end-stage renal disease (ESRD). The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Program staff have participated in meetings, bringing domain expertise and perspectives on current research findings.
|
|
CMS-NIH Leadership Council
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
OD/OSP, NCCIH, NCI, NHGRI, NHLBI, NIA, NIDA, NIDDK, NIMHD, OD/IMOD, OD/OER
|
Facilitates leadership-level development of mutual priorities between both Department of Health and Human Services (HHS) operating divisions.
|